Right Heart Failure Management: Focus on Mechanical Support Options.

Impella RP ProtekDuo Right heart failure TandemHeart ventricular assist devices

Journal

Journal of cardiothoracic and vascular anesthesia
ISSN: 1532-8422
Titre abrégé: J Cardiothorac Vasc Anesth
Pays: United States
ID NLM: 9110208

Informations de publication

Date de publication:
08 2022
Historique:
received: 15 12 2021
revised: 16 02 2022
accepted: 17 02 2022
pubmed: 29 3 2022
medline: 16 6 2022
entrez: 28 3 2022
Statut: ppublish

Résumé

Millions of American adults suffer from right heart failure (RHF), a condition associated with high rates of hospitalization, organ failure, and death. There is a multitude of etiologies and mechanisms that lead to RHF, often in a feedforward spiral of decline. The management of advanced cases of RHF can be particularly difficult. For patients who are refractory to the medical optimization of volume status, hemodynamic and pharmacologic support, and rhythm control, mechanical therapies may be warranted. Currently available mechanical assist devices for RHF include venoarterial extracorporeal oxygenation and right ventricular assist devices, both surgical and percutaneous. Each advanced therapy has its own potential advantages and limitations, and often is appropriate in different clinical contexts. In this review, the authors describe the pathophysiology and medical therapies for RHF and then focus on the different types of advanced therapies that currently exist to help inform medical decision-making for this complicated patient cohort.

Identifiants

pubmed: 35341665
pii: S1053-0770(22)00131-8
doi: 10.1053/j.jvca.2022.02.022
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

3278-3288

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Meena Bhatia (M)

Department of Anesthesiology, University of North Carolina at Chapel Hill, Chapel Hill, NC. Electronic address: meena_bhatia@med.unc.edu.

Shawn Jia (S)

Department of Anesthesiology, University of North Carolina at Chapel Hill, Chapel Hill, NC.

Alan Smeltz (A)

Department of Anesthesiology, University of North Carolina at Chapel Hill, Chapel Hill, NC.

Priya A Kumar (PA)

Department of Anesthesiology, University of North Carolina at Chapel Hill, Chapel Hill, NC; Outcomes Research Consortium, Cleveland, OH.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH